Drugs / LY3084077
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01846702 | May → Dec 2013 | — | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY3084077 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01846702 ↗ |
| Route | Subcutaneous | “Given as a SC injection.” NCT01846702 ↗ |